Literature DB >> 31894530

Curcumin amends Ca2+ dysregulation in microglia by suppressing the activation of P2X7 receptor.

Zhen Wang1, Weihua Ren1, Fucheng Zhao1, Yanru Han1, Caili Liu1, Kui Jia2.   

Abstract

Curcumin (Cur) is widely used as an anti-inflammation agent and has anti-depression potential. Neuroinflammation mediated by Ca2+ channel activation is closely associated with the progression of post-stroke depression (PSD). In the current study, the role of P2X7 receptor (P2X7R) in the anti-PSD function of Cur was explored. Rats were subjected to middle cerebral artery occlusion (MCAO) surgery and chronic mild stress administration to induce PSD symptoms and then treated with Cur. The behaviors of rats were assessed with sucrose preference and forced swim tests. The accumulation of Ca2+ and the systemic inflammatory response in rats were detected. To determine the role of P2X7R in the anti-PSD function of curcumin, the PSD mice were further administrated with P2X7R agonist and antagonist. The administration of Cur attenuated behavior disorders associated with PSD. Moreover, the Ca2+ accumulation and the inflammatory response associated with PSD were also blocked by Cur. Cur also inhibited the activation of Ca2+ channel. The induced activity of P2X7R blocked the function of Cur by maintaining the symptoms of PSD in Cur-treated rats. Collectively, the anti-PSD function of Cur was dependent on the inhibition of P2X7R, which then deactivated Ca2+ channel-mediated inflammatory response associated with PSD progression.

Entities:  

Keywords:  Ca2+ channel; Curcumin; Neuroinflammation; P2X7 receptor; Post-stroke depression

Mesh:

Substances:

Year:  2020        PMID: 31894530     DOI: 10.1007/s11010-019-03668-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Behavioural despair in rats: a new model sensitive to antidepressant treatments.

Authors:  R D Porsolt; G Anton; N Blavet; M Jalfre
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

Review 2.  Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease.

Authors:  Delaram Farzanfar; Yekta Dowlati; Lars E French; Michelle A Lowes; Afsaneh Alavi
Journal:  Skin Pharmacol Physiol       Date:  2018-06-28       Impact factor: 3.479

Review 3.  Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings.

Authors:  Fernanda Neutzling Kaufmann; Marta Gazal; Clarissa Ribeiro Bastos; Manuella Pinto Kaster; Gabriele Ghisleni
Journal:  Eur J Pharmacol       Date:  2016-05-24       Impact factor: 4.432

4.  Frequency of depression after stroke: a systematic review of observational studies.

Authors:  Maree L Hackett; Chaturangi Yapa; Varsha Parag; Craig S Anderson
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

5.  A meta-analysis of cytokines in major depression.

Authors:  Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Helena Liu; Lauren Sham; Elyse K Reim; Krista L Lanctôt
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

Review 6.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

7.  Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent.

Authors:  R C Srimal; B N Dhawan
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

Review 8.  Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis.

Authors:  Luis Ayerbe; Salma Ayis; Charles D A Wolfe; Anthony G Rudd
Journal:  Br J Psychiatry       Date:  2013-01       Impact factor: 9.319

9.  ATP release and purinergic signaling in NLRP3 inflammasome activation.

Authors:  Aurélie Gombault; Ludivine Baron; Isabelle Couillin
Journal:  Front Immunol       Date:  2013-01-08       Impact factor: 7.561

10.  Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection.

Authors:  Bor-Ren Huang; Pei-Chun Chang; Wei-Lan Yeh; Chih-Hao Lee; Cheng-Fang Tsai; Chingju Lin; Hsiao-Yun Lin; Yu-Shu Liu; Caren Yu-Ju Wu; Pei-Ying Ko; Shiang-Suo Huang; Horng-Chaung Hsu; Dah-Yuu Lu
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

View more
  9 in total

1.  Interferon Gamma-Mediated Oxidative Stress Induces Apoptosis, Neuroinflammation, Zinc Ion Influx, and TRPM2 Channel Activation in Neuronal Cell Line: Modulator Role of Curcumin.

Authors:  Mustafa Güzel; Mustafa Nazıroğlu; Orhan Akpınar; Ramazan Çınar
Journal:  Inflammation       Date:  2021-04-17       Impact factor: 4.092

Review 2.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

Review 3.  Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges.

Authors:  Ana Paula Vargas Visentin; Rafael Colombo; Ellen Scotton; Débora Soligo Fracasso; Adriane Ribeiro da Rosa; Catia Santos Branco; Mirian Salvador
Journal:  Oxid Med Cell Longev       Date:  2020-04-14       Impact factor: 6.543

Review 4.  Research Progress on Classical Traditional Chinese Medicine Jieyu Pills in the Treatment of Depression.

Authors:  Yuan Wang; Miao Peng
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-08       Impact factor: 2.570

Review 5.  Curcumin in Depression: Potential Mechanisms of Action and Current Evidence-A Narrative Review.

Authors:  Tahiana Ramaholimihaso; Fayçal Bouazzaoui; Arthur Kaladjian
Journal:  Front Psychiatry       Date:  2020-11-27       Impact factor: 4.157

Review 6.  The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications.

Authors:  John Charles Rotondo; Chiara Mazziotta; Carmen Lanzillotti; Chiara Stefani; Giada Badiale; Giulia Campione; Fernanda Martini; Mauro Tognon
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

Review 7.  An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders.

Authors:  Nicolás Lamanna-Rama; Diego Romero-Miguel; Manuel Desco; Maria Luisa Soto-Montenegro
Journal:  Antioxidants (Basel)       Date:  2022-02-10

Review 8.  Mechanisms Underlying Curcumin-Induced Neuroprotection in Cerebral Ischemia.

Authors:  Feng Fan; Meng Lei
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

Review 9.  Microglia Involves in the Immune Inflammatory Response of Poststroke Depression: A Review of Evidence.

Authors:  Weili Xia; Yong Xu; Yuandong Gong; Xiaojing Cheng; Tiangui Yu; Gongchang Yu
Journal:  Oxid Med Cell Longev       Date:  2022-08-02       Impact factor: 7.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.